STABLE-MATES
Phase 3 Recruiting
272 enrolled
NTS-WBRT in Brain Metastases
Phase 2 Recruiting
41 enrolled
ABLATE
Phase 2 Recruiting
43 enrolled
MINT-2
Phase 2 Recruiting
142 enrolled
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Phase 2 Recruiting
100 enrolled
Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides
Phase 2 Recruiting
50 enrolled
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Phase 2/3 Recruiting
138 enrolled
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
Phase 2 Recruiting
30 enrolled
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Phase 2 Recruiting
160 enrolled
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer
Phase 2 Recruiting
140 enrolled
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Phase 3 Recruiting
206 enrolled
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Phase 1/2 Recruiting
132 enrolled
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 2 Recruiting
222 enrolled
ANDROMEDA
Phase 3 Recruiting
240 enrolled
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Phase 3 Recruiting
478 enrolled
CONVERGE
Phase 2 Recruiting
130 enrolled
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 Recruiting
46 enrolled
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer
Phase 2 Recruiting
42 enrolled
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Phase 2 Recruiting
50 enrolled
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 Recruiting
126 enrolled
PNOC031
Phase 2 Recruiting
70 enrolled
TRIPL
Phase 2 Recruiting
76 enrolled
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2 Recruiting
180 enrolled
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
Phase 2 Recruiting
108 enrolled
WOLF
Phase 2 Recruiting
87 enrolled
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Phase 1 Recruiting
28 enrolled
LAP100
Phase 3 Recruiting
356 enrolled
HOPE
Phase 3 Recruiting
228 enrolled
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.
Phase 3 Recruiting
700 enrolled
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Phase 1 Recruiting
9 enrolled
salVage
Phase NA Recruiting
128 enrolled
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Phase 3 Recruiting
5,951 enrolled
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Phase 1/2 Recruiting
116 enrolled
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
Phase 2 Recruiting
125 enrolled
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
Phase 1 Recruiting
60 enrolled
Hyperpolarized Imaging in Diagnosing Participants With Glioma
Phase 1 Recruiting
140 enrolled
Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients
Phase 2 Recruiting
118 enrolled
Traditional Chinese Medicine Preparation Alleviates Radiotherapy-induced Oral Mucositis in Head and Neck Cancer Patients.
Phase 2 Recruiting
128 enrolled
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Phase 2/3 Recruiting
60 enrolled
CONSORT-PC
Phase 2 Recruiting
40 enrolled
AMPORA
Phase 2 Recruiting
204 enrolled
De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
Phase NA Recruiting
30 enrolled
THUNDER
Phase 2/3 Recruiting
493 enrolled
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Phase 3 Recruiting
380 enrolled
PNOC023
Phase 1 Recruiting
208 enrolled
IVIM & OLINK in Sarcoma
Phase 2 Recruiting
145 enrolled
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
Phase NA Recruiting
188 enrolled
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
Phase NA Recruiting
111 enrolled
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Phase 3 Recruiting
500 enrolled
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
Phase 1 Recruiting
56 enrolled